Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yeah, I was a bit surprised too. I can only assume the impending NAV update doesn't qualify as price sensitive news? Seems a bit illogical though. I don't think management would do so at this point because I think they back themselves to create further value. I was more highlighting that with a low market cap it presents an arbitrage opportunity of sorts, especially for the board- the only risk (as you state) would be the complications of selling the unlisted assets.
Was surprised at buy-assumed they were in a close period as NAV due any moment. Doubt a MBO- to complex to value unquoted and why would they ?
Goes some way to explaining the large buys over the last week. If the company continues at a substantial discount to NAV, with such a low market cap a management buyout would be entirely viable.
http://www.investegate.co.uk/port-erin-biopharma--pebi-/rns/holding-s--in-company/201310041413487830P/ increased to 7% holding
Thanks for the reply as I thought it is due to the quality of the fund and the future upside of Mr Mellons share picks. Shan yes some big big buys for our market cap, 17p+ looks good for next week, I hope to add more on Monday.
I worked in the I.T industry in the 1980's. I would expect a well managed fund producing good returns to trade a pemium to NAV. Expectation of future growth.Just my opinion. I am looking forward to next NAV- hopefully will be in the region I expect. As said before I hope the company will let us know quoted holdings. Pretty confident of the future follow SUMM and PLE, but not i directly nvested-chose this route.
Woah....just noticed those huge buy reported after hours. 50k and 11k both at higher ask prices than mine too!!! Reckon nav report Friday so looking good.
Hi yes this is a great fund, why do you say 10% premium to NAV?
Hi-would remind everyone this is a fund.More sales to-day, punters probably rushed in after PLE and SUMM rises. This will move depending on NAV. We are investing in the companies expertise in investment in the Bio industry-as said before should be at 10% premium to NAV. Let's see what NAV is on 5th. Spotted this early luckily-but I honestly did not expect this sort of rise so fast. My balance is now locked away for the long term and have moved the profit into another company I believe in that, is at a discount to NAV. But not a fund this time..a business with strong earnings growth and great assets.
I have been in solitary confinement for the last 24 hours, due to my less than eloquent description on the MDC thread regarding their suspension and my loss of several thousand pounds. Admin, or other took exception to my vivid description of what I thought about the CEO and his predecessors, hence, I was banned for posting for 24 hours which was lifted at 10.19 am this morning. Good job admin or other aren't in my workplace, as I would be serving a life sentence with no chance of parole :-(
Frdiay 5th Oct for last years NAV report so maybe this time next week for the new one? should be very interesting!
That was me thanks for making me research pebi. printer has worked over time as i got some more today. unfortunately ur still on your own on the other.
Hi Forgot we met on OMIP board. I think you were in the process of printing money and obviously succeeded as you've now made an investment in PEBI Good luck and thanks for the company on my billy no mates board
There is also the chance the 'naive few' took profits having possibly buying at a lower entry than us who bought in later. Getting p****d of with a couple of my stocks, but I'd like to think this one is a keeper, but will use same criteria oldstocbroker used which is topslice if and when 100% return. Looking again at rivaldo's info, we have some very good investments and J Mellon making this his pet project, i think we will see good re-rate after NAV
I know what happened today. We were 10% up for a long time today then as PLE started to sink a few who haven't reseached this probably sold thinking we are really dependant on them when we are NOT as there are many other shares which have increased in value since we bought and as we are in PLE at 2p I think we have a decent buffer !
Thanks guys. I guess just a consolidation day here today which is good for support and prepares us for next wave up.
No probs, glad to spread the word :o))
Looking at inf rivaldo and many others have posted, you can see why I think PEBI is a brilliant investment Good luck
As stated in previous postings, some really good posters here that do great research for us all to share. Thanks very much rivaldo, will have good read later
Many thanks mate. Good work Rivaldo, very thorough.
rivaldo, I hope you don't mind, thanks This PEBI thread is partly due to its stake in Ampliphi Biosciences (APHB), in which I have a decent-sized holding. The APHB thread is here: http://uk.advfn.com/cmn/fbb/thread.php3?id=25624085 PEBI's m/cap with 33.86m shares in issue is £2.37m at 7p. At 30th June 2013 PEBI had £3.6m net assets, or 10.6p per share, comprising £2.92m of investments and £0.7m of uninvested cash. Largest investments at 30th June 2013: Synergy Pharmaceuticals Inc. 277,748 9.52% (plus £10k of warrants in 2012) Summit Corporation plc 212,500 7.29% (when share price was around 4p, 15p at 20/9/13) Arrowhead Research (ARWR) 207,364 7.11% (when share price was around $2, now $4.75) Plethora Solutions Holdings 166,625 5.71% (when share price was around 2p, now 13p) TrovaGene Inc. 137,224 4.70% Pfizer Inc. 136,562 4.68% Nektar Therapeutics 127,303 4.36% Sanofi-ADR 91,349 3.13% 1,356,675 46.51% Plus Ampliphi Biosciences (APHB) 60,000 (when share price was around 15c, now 55c). From the above, shareholdings must be approximately: SUMM : 5,300,000 shares @ 19.25p = £1.03m PLE : 8,300,000 shares @ 14.2p = £1.18m APHB : 500,000 shares @ $0.55 = £0.2m ARWR : 100,000 shares @ $4.80 = £0.3m SGYP : 64,000 shares @ $4.81 = £0.2m TROV : 20,000 shares @ $7.00 = £0.1m NKTR : 11,000 shares @ $13.74 = £0.1m An info sheet from the 2012 Master Investor show lists the following additional holdings totalling approx. £1.55m: Novartis : £156,000 Astellas Pharma : £134,000 Abbot Labs : £111,000 Merck : £91,000 Onyx Pharma : £86,000 H Lundebeck : £73,000 Immunocellar Therapeutics : £68k Celgene : £68,000 Map Pharmaceuticals : £68,000 Eli Lilly : £67,000 Medivir : £66,000 Shire : £66,000 Rigel Pharmaceutical : £64,000 Polymedix : £54,000 Pharmathene : £52,000 Medivation : £51,000 Siga Technologies : £49,000 Sundry other holdings : £214,000, incl Miraculins, Synta, Spiritus, Pacific Biosciences, Biotime, Methylgene, Complete Genomics Here's an old 23 minute interview with Jim Mellon re PEBI which notes that it has 20 holdings. He mentions Medivation, which has increased from $52 at 30/6 to $57.50 now: http://sharecrazy.com/beta/athol-gold/6981/interview-iwth-jim-mellon-on-port-erin-bio-pharma
is free, just an email address and password etc.